Approaches to Continuing COVID-19–Related Clinical Research Practices After the Pandemic—Must Cinderella Leave the Ball?-Reference-Cited by-同舟云学术

Approaches to Continuing COVID-19–Related Clinical Research Practices After the Pandemic—Must Cinderella Leave the Ball?

Published:2023-08-01 Issue:8 Volume:9 Page:1027
ISSN:2374-2437
Container-title:JAMA Oncology
language:en
Short-container-title:JAMA Oncol

Author:

Gerber David E.¹²,Barksdale Elizabeth K. S.³

Affiliation:

1. Harold C. Simmons Comprehensive Cancer Center, The University of Texas Southwestern Medical Center, Dallas

2. Peter O’Donnell Jr. School of Public Health, The University of Texas Southwestern Medical Center, Dallas

3. LUNGevity Foundation, Chicago, Illinois

Abstract

This Viewpoint reviews relevant components of federal regulation and guidance followed during the COVID-19 pandemic that may still be feasible and beneficial after the public health emergency ends.

Publisher

American Medical Association (AMA)

Subject

Oncology,Cancer Research

Link

https://jamanetwork.com/journals/jamaoncology/articlepdf/2805680/jamaoncology_gerber_2023_vp_230006_1691789020.02835.pdf

Reference8 articles.

1. The impact of COVID-19 on clinical trial execution at the Dana-Farber Cancer Institute.;Tolaney;J Natl Cancer Inst,2021

2. Experience, perceptions, and recommendations concerning COVID-19-related clinical research adjustments.;Gerber;J Natl Compr Canc Netw,2020

3. Rethinking cancer clinical trial conduct induced by COVID-19: an academic center, industry, government, and regulatory agency perspective.;Flaherty;Cancer Discov,2021

4. Guidance documents related to coronavirus disease 2019 (COVID-19).;Fed Regist,2023

5. Thoracic oncology clinical trial eligibility criteria and requirements continue to increase in number and complexity.;Garcia;J Thorac Oncol,2017

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Telemedicine and Cancer Clinical Research;The Cancer Journal;2024-01

2. The value of observational registry studies for the next infectious disease emergency;mBio;2023-12-19